Combined treatment effects of radiation and immunotherapy: Studies in an autochthonous prostate cancer model

Satoshi Wada, Timothy J. Harris, Erik Tryggestad, Kiyoshi Yoshimura, Jing Zeng, Hung Rong Yen, Derese Getnet, Joseph F. Grosso, Tullia C. Bruno, Angelo Michael Demarzo, George J. Netto, Andrew Mark Pardoll, Theodore DeWeese, John Wong, Charles G. Drake

Research output: Contribution to journalArticle

Abstract

Purpose: To optimize the combination of ionizing radiation and cellular immunotherapy using a preclinical autochthonous model of prostate cancer. Methods and Materials: Transgenic mice expressing a model antigen under a prostate-specific promoter were treated using a platform that integrates cone-beam CT imaging with 3-dimensional conformal therapy. Using this technology we investigated the immunologic and therapeutic effects of combining ionizing radiation with granulocyte/macrophage colony-stimulating factor-secreting cellular immunotherapy for prostate cancer in mice bearing autochthonous prostate tumors. Results: The combination of ionizing radiation and immunotherapy resulted in a significant decrease in pathologic tumor grade and gross tumor bulk that was not evident with either single-modality therapy. Furthermore, combinatorial therapy resulted in improved overall survival in a preventive metastasis model and in the setting of established micrometastases. Mechanistically, combined therapy resulted in an increase of the ratio of effector-to-regulatory T cells for both CD4 and CD8 tumor-infiltrating lymphocytes. Conclusions: Our preclinical model establishes a potential role for the use of combined radiation-immunotherapy in locally advanced prostate cancer, which warrants further exploration in a clinical setting.

Original languageEnglish (US)
Pages (from-to)769-776
Number of pages8
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume87
Issue number4
DOIs
StatePublished - Nov 15 2013

Fingerprint

Radiation Effects
Immunotherapy
therapy
Prostatic Neoplasms
tumors
Ionizing Radiation
cancer
ionizing radiation
radiation
mice
Prostate
effectors
Tumor-Infiltrating Lymphocytes
Neoplasms
Neoplasm Micrometastasis
Cone-Beam Computed Tomography
macrophages
lymphocytes
metastasis
Therapeutic Uses

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Combined treatment effects of radiation and immunotherapy : Studies in an autochthonous prostate cancer model. / Wada, Satoshi; Harris, Timothy J.; Tryggestad, Erik; Yoshimura, Kiyoshi; Zeng, Jing; Yen, Hung Rong; Getnet, Derese; Grosso, Joseph F.; Bruno, Tullia C.; Demarzo, Angelo Michael; Netto, George J.; Pardoll, Andrew Mark; DeWeese, Theodore; Wong, John; Drake, Charles G.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 87, No. 4, 15.11.2013, p. 769-776.

Research output: Contribution to journalArticle

Wada, Satoshi ; Harris, Timothy J. ; Tryggestad, Erik ; Yoshimura, Kiyoshi ; Zeng, Jing ; Yen, Hung Rong ; Getnet, Derese ; Grosso, Joseph F. ; Bruno, Tullia C. ; Demarzo, Angelo Michael ; Netto, George J. ; Pardoll, Andrew Mark ; DeWeese, Theodore ; Wong, John ; Drake, Charles G. / Combined treatment effects of radiation and immunotherapy : Studies in an autochthonous prostate cancer model. In: International Journal of Radiation Oncology, Biology, Physics. 2013 ; Vol. 87, No. 4. pp. 769-776.
@article{d4f94e374dc44c3c87120361f37c353f,
title = "Combined treatment effects of radiation and immunotherapy: Studies in an autochthonous prostate cancer model",
abstract = "Purpose: To optimize the combination of ionizing radiation and cellular immunotherapy using a preclinical autochthonous model of prostate cancer. Methods and Materials: Transgenic mice expressing a model antigen under a prostate-specific promoter were treated using a platform that integrates cone-beam CT imaging with 3-dimensional conformal therapy. Using this technology we investigated the immunologic and therapeutic effects of combining ionizing radiation with granulocyte/macrophage colony-stimulating factor-secreting cellular immunotherapy for prostate cancer in mice bearing autochthonous prostate tumors. Results: The combination of ionizing radiation and immunotherapy resulted in a significant decrease in pathologic tumor grade and gross tumor bulk that was not evident with either single-modality therapy. Furthermore, combinatorial therapy resulted in improved overall survival in a preventive metastasis model and in the setting of established micrometastases. Mechanistically, combined therapy resulted in an increase of the ratio of effector-to-regulatory T cells for both CD4 and CD8 tumor-infiltrating lymphocytes. Conclusions: Our preclinical model establishes a potential role for the use of combined radiation-immunotherapy in locally advanced prostate cancer, which warrants further exploration in a clinical setting.",
author = "Satoshi Wada and Harris, {Timothy J.} and Erik Tryggestad and Kiyoshi Yoshimura and Jing Zeng and Yen, {Hung Rong} and Derese Getnet and Grosso, {Joseph F.} and Bruno, {Tullia C.} and Demarzo, {Angelo Michael} and Netto, {George J.} and Pardoll, {Andrew Mark} and Theodore DeWeese and John Wong and Drake, {Charles G.}",
year = "2013",
month = "11",
day = "15",
doi = "10.1016/j.ijrobp.2013.07.015",
language = "English (US)",
volume = "87",
pages = "769--776",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Combined treatment effects of radiation and immunotherapy

T2 - Studies in an autochthonous prostate cancer model

AU - Wada, Satoshi

AU - Harris, Timothy J.

AU - Tryggestad, Erik

AU - Yoshimura, Kiyoshi

AU - Zeng, Jing

AU - Yen, Hung Rong

AU - Getnet, Derese

AU - Grosso, Joseph F.

AU - Bruno, Tullia C.

AU - Demarzo, Angelo Michael

AU - Netto, George J.

AU - Pardoll, Andrew Mark

AU - DeWeese, Theodore

AU - Wong, John

AU - Drake, Charles G.

PY - 2013/11/15

Y1 - 2013/11/15

N2 - Purpose: To optimize the combination of ionizing radiation and cellular immunotherapy using a preclinical autochthonous model of prostate cancer. Methods and Materials: Transgenic mice expressing a model antigen under a prostate-specific promoter were treated using a platform that integrates cone-beam CT imaging with 3-dimensional conformal therapy. Using this technology we investigated the immunologic and therapeutic effects of combining ionizing radiation with granulocyte/macrophage colony-stimulating factor-secreting cellular immunotherapy for prostate cancer in mice bearing autochthonous prostate tumors. Results: The combination of ionizing radiation and immunotherapy resulted in a significant decrease in pathologic tumor grade and gross tumor bulk that was not evident with either single-modality therapy. Furthermore, combinatorial therapy resulted in improved overall survival in a preventive metastasis model and in the setting of established micrometastases. Mechanistically, combined therapy resulted in an increase of the ratio of effector-to-regulatory T cells for both CD4 and CD8 tumor-infiltrating lymphocytes. Conclusions: Our preclinical model establishes a potential role for the use of combined radiation-immunotherapy in locally advanced prostate cancer, which warrants further exploration in a clinical setting.

AB - Purpose: To optimize the combination of ionizing radiation and cellular immunotherapy using a preclinical autochthonous model of prostate cancer. Methods and Materials: Transgenic mice expressing a model antigen under a prostate-specific promoter were treated using a platform that integrates cone-beam CT imaging with 3-dimensional conformal therapy. Using this technology we investigated the immunologic and therapeutic effects of combining ionizing radiation with granulocyte/macrophage colony-stimulating factor-secreting cellular immunotherapy for prostate cancer in mice bearing autochthonous prostate tumors. Results: The combination of ionizing radiation and immunotherapy resulted in a significant decrease in pathologic tumor grade and gross tumor bulk that was not evident with either single-modality therapy. Furthermore, combinatorial therapy resulted in improved overall survival in a preventive metastasis model and in the setting of established micrometastases. Mechanistically, combined therapy resulted in an increase of the ratio of effector-to-regulatory T cells for both CD4 and CD8 tumor-infiltrating lymphocytes. Conclusions: Our preclinical model establishes a potential role for the use of combined radiation-immunotherapy in locally advanced prostate cancer, which warrants further exploration in a clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=84886090883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886090883&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2013.07.015

DO - 10.1016/j.ijrobp.2013.07.015

M3 - Article

C2 - 24064321

AN - SCOPUS:84886090883

VL - 87

SP - 769

EP - 776

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -